Ad
related to: idexx stocksuperstockscreener.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40. The pet healthcare company reported sales of $954.3 ...
IDEXX Laboratories, Inc. is an American multinational corporation [3] [4] engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.
Shares of leading pet healthcare diagnostics provider Idexx Laboratories (NASDAQ: IDXX) were up by 9% this week as of 4 p.m. ET Thursday, according to data provided by S&P Global Market Intelligence.
Idexx Laboratories exceeded earnings expectations for Q4 2024, ... After all, Stock Advisor’s total average return is 903% — a market-crushing outperformance compared to 176% for the S&P 500.*
The stock of IDEXX Laboratories (NAS:IDXX, 30-year Financials) shows every sign of being significantly overvalued, according to GuruFocus Value calculation.
IDEXX's total sales in the quarter rose about 9% to $916 million, but missed analysts' average estimate of $926.16 million. Its quarterly profit was at $2.53 per share, compared with $2.15 per ...
The more IDEXX Laboratories (NAS: IDXX) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy ...
However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. A cloudy Some Numbers at IDEXX Laboratories that Make Your Stock Look Good
Ad
related to: idexx stocksuperstockscreener.com has been visited by 10K+ users in the past month